[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $nbi Neurocrine Biosciences' product sales are outperforming competitors like CRMD, TGTX, AXSM, and TARS, yet the company trades at a fraction of their market cap. This disconnect is prompting discussions about valuation and market perception. ### About $nbi Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases. ### Engagements: XXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$nbi/time-series/interactions.tsv) Current Value: XXX Daily Average: XXX X Week: XXX -XX% X Month: XXXXXX +43% X Months: XXXXXXX -XX% X Year: XXXXXXX +381% 1-Year High: XXXXX on 2025-10-04 1-Year Low: X on 2025-09-23 Engagements by network (24h): X: XXX ### Mentions: X (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$nbi/time-series/posts_active.tsv) Current Value: X Daily Average: X X Week: XX -XX% X Month: XX +113% X Months: XXX -XXXX% X Year: XXX +159% 1-Year High: XX on 2025-11-20 1-Year Low: X on 2025-01-26 Mentions by network (24h): X: XX ### Creators: X (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$nbi/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $nbi in the last XX hours which is no change from in the previous XX hours Daily Average: X X Week: X -XX% X Month: XX +73% X Months: XX -X% X Year: XX +33% 1-Year High: XX on 2025-11-20 1-Year Low: X on 2024-12-11 The most influential creators that mention $nbi in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X | XXXXX | X | XXX | [View More](/list/creators/$nbi/100) ### Top $nbi Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$CRMD DefenCath product sales by quarter post launch v the same from $TGTX $AXSM $ARQT & $TARS CRMD is outselling all X but trades at a fraction of all X market cap This is not to bash the X but to understand the disconnect. Sincere guidance appreciated $XBI $IBB $NBI $IBBQ" [X Link](https://x.com/NightOwlBiotech/status/1989085635223879847) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-11-13T21:39Z 1666 followers, 3737 engagements "$DAWN Ojemda US product sales by quarter post launch v $CTIC & $ZGNX who were both acquired for enterprise values of $1.7B This is not investment advice. $NBI $XBI $IBB" [X Link](https://x.com/NightOwlBiotech/status/1986124639760712180) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-11-05T17:33Z 1666 followers, 1573 engagements "Updated $SNDX valuation v. actual US product sales compared to peers that exited via M&A & those still independent. $ARQT $AVDL $AXSM $TGTX may not be truly apples to apples. This is not investment advice. We're merely sharing X valuation perspective $XBI $IBB $IBBQ $NBI" [X Link](https://x.com/NightOwlBiotech/status/1985481633172959270) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-11-03T22:58Z 1663 followers, 1439 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Neurocrine Biosciences' product sales are outperforming competitors like CRMD, TGTX, AXSM, and TARS, yet the company trades at a fraction of their market cap. This disconnect is prompting discussions about valuation and market perception.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXXX +43%
X Months: XXXXXXX -XX%
X Year: XXXXXXX +381%
1-Year High: XXXXX on 2025-10-04
1-Year Low: X on 2025-09-23
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: XX -XX%
X Month: XX +113%
X Months: XXX -XXXX%
X Year: XXX +159%
1-Year High: XX on 2025-11-20
1-Year Low: X on 2025-01-26
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $nbi in the last XX hours which is no change from in the previous XX hours
Daily Average: X
X Week: X -XX%
X Month: XX +73%
X Months: XX -X%
X Year: XX +33%
1-Year High: XX on 2025-11-20
1-Year Low: X on 2024-12-11
The most influential creators that mention $nbi in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @NightOwlBiotech | X | XXXXX | X | XXX |
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$CRMD DefenCath product sales by quarter post launch v the same from $TGTX $AXSM $ARQT & $TARS CRMD is outselling all X but trades at a fraction of all X market cap This is not to bash the X but to understand the disconnect. Sincere guidance appreciated $XBI $IBB $NBI $IBBQ"
X Link @NightOwlBiotech 2025-11-13T21:39Z 1666 followers, 3737 engagements
"$DAWN Ojemda US product sales by quarter post launch v $CTIC & $ZGNX who were both acquired for enterprise values of $1.7B This is not investment advice. $NBI $XBI $IBB"
X Link @NightOwlBiotech 2025-11-05T17:33Z 1666 followers, 1573 engagements
"Updated $SNDX valuation v. actual US product sales compared to peers that exited via M&A & those still independent. $ARQT $AVDL $AXSM $TGTX may not be truly apples to apples. This is not investment advice. We're merely sharing X valuation perspective $XBI $IBB $IBBQ $NBI"
X Link @NightOwlBiotech 2025-11-03T22:58Z 1663 followers, 1439 engagements
/topic/$nbi